IO Biotech Inc. (NASDAQ:IOBT) saw an upside of 3.21% to $1.94 after adding $0.06 on Monday. The 5-day average trading volume is 116,734 shares of the company’s common stock. It has gained $2.1800 in the past week and touched a new high 4 times within the past 5 days. An average of 64,759 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 211,035.
IOBT’s 1-month performance is 7.79% or $0.1900 on its low of $1.7200 reached on 07/14/23. The company’s shares have touched a 52-week low of $1.56 and high of $4.68, with the stock’s rally to the 52-week high happening on 01/23/23. YTD, IOBT has lost -15.64% or -$0.3100 and has reached a new high 5 times. However, the current price is down -58.54% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
IOBT stock has a beta of -0.65. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 0.45.
IO Biotech Inc.’s quick ratio for the period ended March 30 was 12.80, with the current ratio over the same period at 12.80. The firm’s gross profit as reported stood at $0.3 million against revenue of $71.42 million.
Earnings Surprise
For the quarterly period ending March 30 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -0.94% to -$17.04 million, while revenue of -$20.07 million was -17.78% off the previous quarter. Analysts expected IOBT to announce -$0.7 per share in earnings in its latest quarter, but it posted -$0.59, representing a 15.70% surprise. EBITDA for the quarter stood at more than -$17.88 million. IOBT stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 12.63 million, with total debt at $2.83 million. Shareholders hold equity totaling $28.82 million.
Let’s look briefly at IO Biotech Inc. (IOBT) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 04 August was 65.50% to suggest the stock is trending Neutral, with historical volatility in this time period at 38.75%.
The stock’s 5-day moving average is $1.9000, reflecting a +8.15% or $0.1500 change from its current price. IOBT is currently trading +9.34% above its 20-day SMA, -18.44% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -7.44% and SMA200 by-19.76%.
Stochastic %K and %D was 57.93% and 59.79% and the average true range (ATR) pointed at 0.1403. The RSI (14) points at 58.73%, while the 14-day stochastic is at 57.78% with the period’s ATR at 0.1393. The stock’s 9-day MACD Oscillator is pointing at 0.0256 and 0.0405 on the 14-day charts.
Analyst Ratings
Analysts offering their rating for IOBT stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate IOBT as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 5 have offered a “buy” rating.
What is IOBT’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $11.00 and a high of $15.00, with their median price target at $11.50. Looking at these predictions, the average price target given by analysts is for IO Biotech Inc. (IOBT) stock is $12.25.
